(FMX) Fomento Economico Mexicano - Overview
Stock: Beverages, Retail, Fuel, Drugstores, Logistics
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 7.80% |
| Yield on Cost 5y | 13.53% |
| Yield CAGR 5y | 55.44% |
| Payout Consistency | 87.9% |
| Payout Ratio | 101.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 26.4% |
| Relative Tail Risk | -7.03% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.09 |
| Alpha | 33.22 |
| Character TTM | |
|---|---|
| Beta | 0.265 |
| Beta Downside | 0.098 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.28% |
| CAGR/Max DD | 0.38 |
Description: FMX Fomento Economico Mexicano January 29, 2026
Fomento Económico Mexicano, S.A.B. de C.V. (NYSE: FMX) is the world’s largest Coca-Cola franchise bottler, distributing the brand across Mexico and nine other Latin American countries while also operating a diversified portfolio of proximity-retail concepts-including OXXO convenience stores, OXXO GAS fuel stations, and various drugstore chains-under its “Others” segment.
In FY 2023 the company reported net revenue of $15.9 billion USD, with OXXO contributing roughly $7.2 billion and delivering a 5.4 % same-store sales growth year-over-year; the total OXXO footprint now exceeds 2,200 stores across Mexico and Latin America, and its European kiosk portfolio adds another ≈ 400 points of sale.
Key economic drivers include the resilience of low-income consumer spending on convenience goods, ongoing inflationary pressure that squeezes beverage margins, and currency exposure-particularly the peso-dollar exchange rate, which historically adds a 2-3 % upside to consolidated earnings when the peso weakens.
For a deeper quantitative view of FMX’s valuation dynamics, a quick look at ValueRay’s analyst models can help you spot any mispricings before the next earnings release.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 22.94b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 15.32 > 1.0 |
| NWC/Revenue: 0.50% < 20% (prev 17.35%; Δ -16.85% < -1%) |
| CFO/TA 2.21 > 3% & CFO 97.53b > Net Income 22.94b |
| Net Debt (7.30b) to EBITDA (114.12b): 0.06 < 3 |
| Current Ratio: 1.34 > 1.5 & < 3 |
| Outstanding Shares: last quarter (33.5m) vs 12m ago -98.13% < -2% |
| Gross Margin: 41.15% > 18% (prev 0.41%; Δ 4074 % > 0.5%) |
| Asset Turnover: 183.5% > 50% (prev 88.35%; Δ 95.13% > 0%) |
| Interest Coverage Ratio: 3.92 > 6 (EBITDA TTM 114.12b / Interest Expense TTM 18.52b) |
Altman Z'' 3.36
| A: 0.09 (Total Current Assets 16.17b - Total Current Liabilities 12.05b) / Total Assets 44.07b |
| B: 0.33 (Retained Earnings 14.72b / Total Assets 44.07b) |
| C: 0.16 (EBIT TTM 72.62b / Avg Total Assets 446.99b) |
| D: 0.54 (Book Value of Equity 14.04b / Total Liabilities 26.21b) |
| Altman-Z'' Score: 3.36 = A |
Beneish M -4.00
| DSRI: 0.09 (Receivables 4.05b/41.49b, Revenue 820.12b/750.88b) |
| GMI: 1.00 (GM 41.15% / 41.30%) |
| AQI: 0.95 (AQ_t 0.28 / AQ_t-1 0.29) |
| SGI: 1.09 (Revenue 820.12b / 750.88b) |
| TATA: -1.69 (NI 22.94b - CFO 97.53b) / TA 44.07b) |
| Beneish M-Score: -5.48 (Cap -4..+1) = AAA |
What is the price of FMX shares?
Over the past week, the price has changed by +5.76%, over one month by +11.67%, over three months by +20.66% and over the past year by +33.18%.
Is FMX a buy, sell or hold?
- StrongBuy: 3
- Buy: 4
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the FMX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 109.4 | -0.9% |
| Analysts Target Price | 109.4 | -0.9% |
| ValueRay Target Price | 131.5 | 19.1% |
FMX Fundamental Data Overview February 04, 2026
P/E Trailing = 57.7088
P/E Forward = 33.0033
P/S = 0.0437
P/B = 2.541
P/EG = 1.9926
Revenue TTM = 820.12b MXN
EBIT TTM = 72.62b MXN
EBITDA TTM = 114.12b MXN
Long Term Debt = 130.82b MXN (from longTermDebt, last quarter)
Short Term Debt = 1.76b MXN (from shortTermDebt, last quarter)
Debt = 14.05b MXN (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.30b MXN (from netDebt column, last quarter)
Enterprise Value = 578.73b MXN (628.10b + Debt 14.05b - CCE 63.41b)
Interest Coverage Ratio = 3.92 (Ebit TTM 72.62b / Interest Expense TTM 18.52b)
EV/FCF = 79.15x (Enterprise Value 578.73b / FCF TTM 7.31b)
FCF Yield = 1.26% (FCF TTM 7.31b / Enterprise Value 578.73b)
FCF Margin = 0.89% (FCF TTM 7.31b / Revenue TTM 820.12b)
Net Margin = 2.80% (Net Income TTM 22.94b / Revenue TTM 820.12b)
Gross Margin = 41.15% ((Revenue TTM 820.12b - Cost of Revenue TTM 482.64b) / Revenue TTM)
Gross Margin QoQ = 39.93% (prev 40.65%)
Tobins Q-Ratio = 13.13 (Enterprise Value 578.73b / Total Assets 44.07b)
Interest Expense / Debt = 38.48% (Interest Expense 5.40b / Debt 14.05b)
Taxrate = 29.65% (3.74b / 12.61b)
NOPAT = 51.09b (EBIT 72.62b * (1 - 29.65%))
Current Ratio = 1.34 (Total Current Assets 16.17b / Total Current Liabilities 12.05b)
Debt / Equity = 1.05 (Debt 14.05b / totalStockholderEquity, last quarter 13.38b)
Debt / EBITDA = 0.06 (Net Debt 7.30b / EBITDA 114.12b)
Debt / FCF = 1.00 (Net Debt 7.30b / FCF TTM 7.31b)
Total Stockholder Equity = 105.93b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.13% (Net Income 22.94b / Total Assets 44.07b)
RoE = 21.65% (Net Income TTM 22.94b / Total Stockholder Equity 105.93b)
RoCE = 30.67% (EBIT 72.62b / Capital Employed (Equity 105.93b + L.T.Debt 130.82b))
RoIC = 22.71% (NOPAT 51.09b / Invested Capital 224.99b)
WACC = 7.33% (E(628.10b)/V(642.15b) * Re(6.89%) + D(14.05b)/V(642.15b) * Rd(38.48%) * (1-Tc(0.30)))
Discount Rate = 6.89% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -86.32%
[DCF Debug] Terminal Value 75.63% ; FCFF base≈8.72b ; Y1≈6.39b ; Y5≈3.64b
Fair Price DCF = 206.2 (EV 78.54b - Net Debt 7.30b = Equity 71.23b / Shares 345.5m; r=7.33% [WACC]; 5y FCF grow -31.44% → 2.90% )
[DCF Warning] FCF declining rapidly (-31.44%), DCF may be unreliable
EPS Correlation: 4.73 | EPS CAGR: -41.34% | SUE: -3.02 | # QB: 0
Revenue Correlation: 88.53 | Revenue CAGR: 9.71% | SUE: -0.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.68 | Chg30d=+0.003 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=4.58 | Chg30d=-0.029 | Revisions Net=+3 | Growth EPS=+38.2% | Growth Revenue=+7.8%